CSL Limited (CSLLY)
Manufactures blood plasma treatments, vaccines, and therapies for serious diseases worldwide.
$21.04+0.03%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-50.6%
The outlook
CSL Limited is trading near the lower end of its 52-week range, with the average analyst target sitting roughly 15% above the current price. The single analyst covering the stock holds a neutral stance, while the stock shows mixed performance against its moving averages, suggesting some near-term uncertainty.
What’s behind the score
Analyst consensusHold — 3.0 avg of 1 analysts
Price trendMixed vs its moving averages
52-week range17% of the way from its 52-week low to high
Price targetAvg target +15% vs current price
Market cap
$40.31B
52-wk high
$44.86
52-wk low
$16.01
50-day avg
$19.26
200-day avg
$25.77
Trailing P/E
13.7